Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research-Hampton, Virginia

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity’s Family Medicine research site in Hampton partners with Hampton Family Practice to conduct clinical trials related to general medicine and infectious diseases. Typical studies at this site involve medications for acne, diabetes, high cholesterol, and other conditions. This site also performs vaccine studies for people of all ages. Acquired by Velocity in 2022, the Hampton location was founded earlier in 2022 as part of Meridian Clinical Research. Through the partnership with Hampton Family Practice, the site is easily accessible to thousands of patients around Hampton and Newport News, including those established with the practice and diverse populations. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Hampton team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research

Business Status

Source: Google. OPEN

Business Category

Source: Google. Medical clinic

Business Subcategory

Source: Google. Medical clinic
Source: Trial-derived.
14Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
6Active Trials
Source: Trial-derived.
7Completed Trials
Source: Trial-derived.
18Unique Conditions
Source: Trial-derived.
10Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. SARS-CoV-2 (3)Source: Trial-derived. Acute Gastroenteritis (1)Source: Trial-derived. Asthma (1)Source: Trial-derived. Common Warts (Verruca Vulgaris) (1)Source: Trial-derived. COPD (1)Source: Trial-derived. Coronavirus Disease (COVID-19) (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Dermatitis Atopic (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (5)Source: Trial-derived. DevPro Biopharma (2)Source: Trial-derived. Uniquity One (UNI) (2)Source: Trial-derived. CSL Behring (1)Source: Trial-derived. LumiraDx UK Limited (1)Source: Trial-derived. Merck Sharp & Dohme LLC (1)Source: Trial-derived. Nielsen BioSciences, Inc. (1)Source: Trial-derived. Sanofi (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Hemagglutination inhibition (HAI) assay